The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in […]
With the arrival of new therapeutic tracers, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of […]
The course will offer a comprehensive overview of basic, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of FDG (FDG) Brain PET, amyloid […]
The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights […]
Artificial intelligence with the development of deep learning has found numerous applications in the medical field over the past few years, including more specifically that of medical imaging. This includes […]
Radionuclide Theranostics is evolving and expanding in the field of nuclear medicine in various clinical settings. Its principle is based on therapeutic interventions after imaging to confirm the presence of […]
more information coming soon Faculty Event Overview
More information coming soon Learning Objectives Target Audience Faculty Registration Details
more information coming soon Faculty Event Overview
more information coming soon Faculty Event Overview
More information coming soon Learning Objectives Target Audience Faculty Registration Details
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
